Faron Pharmaceuticals Oy (FARN)

Company name:Faron Pharmaceuticals Oy
EPIC:FARNTrading Currency:GBX
Market Sector:AMQ1ISIN:FI4000153309
Market Segment:ASQ1Share Type:DE
WWW Address:http://www.faronpharmaceuticals.com/Description:ORD NPV (DI)
 Price Price Change [%] Bid Offer Open High Low Volume
 297.50 images.advfn.com/imagesnew/2/gb/up 10.0 [3.48] 290.00 305.00 292.50 305.00 292.50 98,699
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 117.08 39.36 0.25 -54.95 - - - 316.50 - 51.00

Faron Pharmaceuticals Oy Key Figures

(at previous day's close)
Market Cap.117.08m
Shares In Issue39.36m
Prev. Close287.50
PE Ratio- 
Dividend Yield-%
EPS - basic-54.95p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-46.90p
Return On Equity (ROE)-5,428.65%
Operating Margin-105,705.26%
PEG Factor- 
EPS Growth Rate14.47%
Dividends PS Growth Rate-%
Net Debt3.21m
Gross Gearing95.38%
Quick Assets6.71m
Net Working Capital1.54m
Intangibles / Fixed Assets96.86%
Turnover PS0.04p
Pre-Tax Profit PS-45.89p
Retained Profit PS-45.89p
Cash PS9.29p
Net Cash PS-3.83p
Net Tangible Asset Value PS *-0.35p
Net Asset Value PS0.85p
Spread15.00 (4.92%) 

Faron Pharmaceuticals Oy Balance Sheet


Share Price Performance

Sample Period HighLow
1 week316.50182.50
4 weeks316.50142.50
12 weeks316.5080.50
1 year316.5051.00

Share Price Chart (5 years)

Faron Pharmaceuticals Oy Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week192.50105.0054.55182.500.53266.64
4 weeks207.5090.0043.37142.500.34218.62
12 weeks106.50191.00179.3480.500.26174.40
26 weeks119.00178.50150.0080.500.20156.53
1 year72.50225.00310.3451.000.18120.99
3 years255.0042.5016.6751.000.15143.72
5 years282.5015.005.3151.000.13144.59

Faron Pharmaceuticals Oy Key Management Ratios

Faron Pharmaceuticals Oy Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 10.23 
Tobin's Q Ratio (excl. intangibles)10.62 
Dividend Yield-%
Market-to-Book Ratio351.91 
Price-to-Pre-Tax Profit PS-6.48 
Price-to-Retained Profit PS-6.48 
Price-to-Cash Flow PS-6.34 
Price-to-Sales PS6,852.99 
Price-to-Net Tangible Asset Value PS-840.04 
Price-to-Cash PS32.02 
Net Working Capital PS3.92 
Price Pct to Working Capital PS75.92%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Faron Pharmaceuticals Oy Financial Ratios

(Leverage Ratios)
Debt Ratio83.61%
Debt-to-Equity Ratio5.10 
Debt-to-Equity Ratio (excl. Intgbl)-12.17 
Debt-to-Equity Market Value0.01 
Net Gearing44.55%
Net Gearing (excl. Intangibles)47.68%
Gross Gearing95.38%
Gross Gearing (excl. Intangibles)102.07%
Gearing Under 1 Year71.79%
Gearing Under 1 Year (excl. Intgbl)76.84%
(Liquidity Ratios)
Net Working Capital to Total Assets21.43%
Current Ratio1.30 
Quick Ratio (Acid Test)1.30 
Liquidity Ratio0.71 
Cash & Equiv/Current Assets54.52%
(Solvency Ratios)
Enterprise Value115.12m
CFO/Attributable Profit- 
Total Debt/Equity Market Value0.06 
Total Debt/Sales401.68 
Total Debt/Pre-Tax Profit-0.38 
Total Debt6.86m
Total Debt/Net Current Assets4.45%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs2 
Beta (60-Mnth)Beta (36-Mnth)

Faron Pharmaceuticals Oy Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-889.85%
Return On Assets (ROA)-157.82%
Net Profit Margin-105,715.79%
Assets Turnover0.00 
Return On Equity (ROE)-5,428.65%
Return On Investment (ROI)-397.48%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-105,715.79%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.01 
Fixed Assets Turnover0.04 
Current Assets Turnover0.00 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales669.86 
Debt Collection Period92,111.00Days

Faron Pharmaceuticals Oy Dividends

Sorry No Data Available

Faron Pharmaceuticals Oy Fundamentals

 31 Dec 2015 (EUR)31 Dec 2016 (EUR)31 Dec 2017 (EUR)31 Dec 2018 (EUR)
pre tax profit-6.15--9.22-799.57%-21.06--20.08-m
attributable profit-6.19--9.29-806.07%-21.06--20.09-m
retained profit-6.19--9.29-806.07%-21.06--20.09-m
eps - basic-30.00 -39.00 -76.00 -65.00 
eps - diluted-30.00 -39.00 -76.00 -65.00 
dividends per share- - - - 

Faron Pharmaceuticals Oy Balance Sheet

 31 Dec 2015 (EUR)31 Dec 2016 (EUR)31 Dec 2017 (EUR)31 Dec 2018 (EUR)
 31 Dec 2015 (EUR)31 Dec 2016 (EUR)31 Dec 2017 (EUR)31 Dec 2018 (EUR)
fixed assets fixed assets0.030.19%0.020.12%0.020.15%0.020.21%m
intangibles intangibles1.006.75%0.935.40%0.332.18%0.536.56%m
fixed investments fixed investments--%--%--%--%m
current assets - other current assets - other--%--%--%--%m
stocks stocks0.654.38%1.458.39%--%--%m
debtors debtors2.0713.99%3.4019.69%5.2335.13%3.3942.40%m
cash & securities cash & securities11.0774.68%11.4866.40%9.3162.54%4.0750.82%m
creditors - short creditors - short2.2014.82%4.3725.28%8.0654.11%5.7571.79%m
creditors - long creditors - long1.459.76%2.0311.76%2.0914.03%1.8923.58%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves11.1875.42%10.8862.95%4.7431.86%0.374.62%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Faron Pharmaceuticals Oy Cash Flow Statement

31 Dec 2015 (EUR)31 Dec 2016 (EUR)31 Dec 2017 (EUR)31 Dec 2018 (EUR)
Operating CF-7.15-8.45-18.36-20.53m
Pre-Financing CF-7.25-8.54-18.46-20.82m
Retained CF10.830.41-1.88-5.28m

Faron Pharmaceuticals Oy Brokers

Broker infomation is not available for this class of stock.
Your Recent History
Faron Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20191205 14:52:02